
Sign up to save your podcasts
Or


[Running time: 13 minutes]
The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find.
Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and to help the patients and physicians caught in the middle of a continuing debate on the wisdom of screening.
Physician’s First Watch coverage of the JAMA studies and editorial (free)
By NEJM Group4.5
5656 ratings
[Running time: 13 minutes]
The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find.
Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and to help the patients and physicians caught in the middle of a continuing debate on the wisdom of screening.
Physician’s First Watch coverage of the JAMA studies and editorial (free)

7,870 Listeners

319 Listeners

2,050 Listeners

124 Listeners

502 Listeners

298 Listeners

903 Listeners

266 Listeners

3,387 Listeners

113,515 Listeners

89 Listeners

5 Listeners

90 Listeners

521 Listeners

2,577 Listeners

367 Listeners

16,576 Listeners

58 Listeners

31 Listeners

67 Listeners